Illumina Settles BGI Patent Battles For $325M
Executive Summary
The settlement resolves a total of eight lawsuits between the companies on genetic sequencing technology and alleged antitrust violations.
You may also be interested in...
Jury Awards Nearly $334M To MGI Tech In Illumina Patent Suit
The jury said the infringement, which involved patents on two-channel sequencing chemistry technology, had been “willful” and turned down Illumina’s counterclaims.
Eight Indicted In Alleged Genetic Testing Fraud
The eight had ties to a group of Tennessee labs that reportedly paid physicians to order medically unnecessary testing, billing Medicare more than $150m in five years.
Medtech Industry Mourns US Rep. Jackie Walorski
Indiana Republican Congresswoman Jackie Walorski, who died in a car crash Wednesday, was a strong proponent of device industry priorities such as device tax repeal and Medicare coverage for innovative technologies.